Day 2 (20 Nov)

• Opening Remarks
  Ahmad Izuanuddin Ismail Chairperson Malaysia
• Introduction to the 2027 Report and Discussion of Early Disease
  David Halpin Speaker United Kingdom
• Update on Biologic Therapy in the 2027 Report
  Antonio Anzueto Speaker United States
• Update on Exacerbations in the 2027 Report
  Wisia Wedzicha Speaker United Kingdom
• Leveraging on Digital Tools for COPD Management in 2027 and Beyond
  Pang Yong Kek Speaker Malaysia
• Discussion, Open Forum, & Closing Remarks
  Ahmad Izuanuddin Ismail Chairperson Malaysia

  Pang Yong Kek Chairperson Malaysia

• Ethical Challenges and Responses in Treating and Preventing TB
  Diego Silva Speaker Australia
• Drug-Resistant Tuberculosis in Malaysia: From Injectable Regimens to All-Oral Therapy
  Zamzurina Abu Bakar Speaker Malaysia
• From Control to Elimination: Evaluating Malaysia’s Tuberculosis Journey and Future Priorities
  Mat Zuki Bin Mat Jaeb Speaker Malaysia
• Q&A

• From Clinical Phenotypes to Treatable Traits in Bronchiectasis
  Ernest Mau Ern Poh Speaker Malaysia
• Therapeutic Advances in Bronchiectasis
  Anne Chang Speaker Australia
• Co-morbidities in Bronchiectasis
  Herbert Wang Chun Kwok Speaker Hong Kong
• Q&A

• A New Horizon in ILD Treatment: Looking Beyond Nintedanib and Pirfenidone
  Ganesh Raghu Speaker United States
• Approach to Evaluation and Management of ILA
  Jin Woo Song Speaker Republic of Korea
• The 2025 ATS/ERS Classification and Implications in Clinical Practice
  Yasuhiko Nishioka Speaker Japan
• Q&A

• AO01 - Asthma
  Fanny Ko Chairperson Hong Kong

  Hema Yamini Devi Ramarmuty Chairperson Malaysia
• AO02 - Bronchoscopy & Interventional Pulmonology
• AO03 - COPD
• AO04 - Critical Care Medicine
• AO05 - Environmental & Occupational Health and Epidemiology
• AO06 - Lung Cancer
• AO07 - Respiratory Infections (Non-Tuberculous)
  King Pui Florence Chan Chairperson Hong Kong

• Achieving Asthma Remission in Resource-Limited Settings: Practical Strategies Beyond Biologics
  Azza Omar Speaker Malaysia
• Biomarker-directed Treatment of Acute Exacerbations of Asthma
  Anthony Yii Speaker Singapore
• Predicting & Personalising: The Future of Asthma from Remission to Cure
  Peter Gibson Speaker Australia
• Q&A

• The Global Spectrum of Respiratory Diseases Caused by Exposure to Mineral Dusts in the Workplace
  Benoit Nemery Speaker Belgium
• Introduction of Anti-fibrotics Treatment in Combined Fibrosis and Pneumoconiosis and Prerequisites for Field Application
  Jun-Pyo Myong Speaker Republic of Korea
• Occupational Lung Diseases in Malaysia
  Siti Munira Yasin Speaker Malaysia
• Q&A

• AI Radiomics for the Early Detection of Lung Cancer
  Ren Yuan Speaker Canada
• Overview of Lung Cancer in the Asia Pacific. Is It Different from Its Counterpart from Outside Asia?
  Chong Kin Liam Speaker Malaysia
• New Challenges of Lung Cancer Management in the Asian Pacific Region
  Yuh-Min Chen Speaker Taiwan
• Q&A

• Precision Medicine in Asthma: Eosinophils and Biologics
  Min Suk Yang Speaker Republic of Korea
• Phenotypes of Childhood Wheeze: A Trajectory Analysis
  Takao Fujisawa Speaker Japan
• The Progression from Infant Wheezing to Asthma in Children: Modern Data Approaches
  Jessie Anne de Bruyne Speaker Malaysia
• Q&A

• AO08 - Bronchoscopy & Interventional Pulmonology
  Arvindran Alaga Chairperson Malaysia
• AO09 - Clinical Respiratory Medicine
  Asif Mujtaba Mahmud Chairperson Bangladesh
• AO10 - Interstitial Lung Disease
  Md Ali Hossain Chairperson Bangladesh
• AO11 - Pulmonary Circulation
• AO12 - Respiratory Infections (Non-Tuberculous)
  Neranjan Dissanayake Chairperson Sri Lanka
• AO13 - Respiratory Neurobiology & Sleep
  DEWAN AZMAL HUSSAIN Chairperson Bangladesh
• AO14 - Tuberculosis
  Abdul Razak Abdul Muttalif Chairperson Malaysia

• Unveiling Small Airways as Assessable and Treatable Trait
  Claude Farah Speaker Australia
• Bridging Guidelines & Rcts to Clinical Practice
  Jean Bourbeau Speaker Canada
• Expanding Extra-Fine Triple Evidence in Real Life
  Chin Kook Rhee Speaker Republic of Korea

• Advancing COPD Management: From Disease Instability to Precision Use of Biologic Therapies
  Antonio Anzueto Speaker United States

• Covid-19/Influenzae
  Angela Branche Speaker United States
• Pneumococcal Vaccination
  Kazuko Yamamoto Speaker Japan
• Respiratory Syncytial Virus
  Philip Eng Speaker Singapore
• Q&A

• Can We Predict and Prevent Bronchiectasis Exacerbations Accordingly?
  Anne Chang Speaker Australia
• Long-term Prognosis of Childhood Chronic Suppurative Lung Disease
  Anna Marie Nathan Speaker Malaysia
• The Intersection Between Protracted Bacterial Bronchitis (PBB) and Bronchiectasis - Clinical and Scientific Aspects
  Stephanie Yerkovich Speaker Australia
• Q&A

• Obesity and Sleep Apnoea: Beyond Airway Obstruction
  Ahmad Izuanuddin Ismail Speaker Malaysia
• Obesity Hypoventilation Syndrome: Still the Forgotten Disorder?
  Yizhong Zheng Speaker Australia
• Integrating Weight Management into Sleep (Respiratory) Practice: From Passive Advice to Active Intervention
  Brendon Yee Speaker Australia
• Q&A

• Building a Truly Global Evidence Base: Capitalising Asian Diversity in Respiratory Research
  Michelle Gong Speaker United States
• Asian Diversity and Personalised Respiratory Medicine Worldwide: Challenges and Solutions
  Shigeo Muro Speaker Japan
• From Equity to Partnership: Transforming Global Respiratory Research Collaborations
  Marc Miravitlles Speaker Spain
• Q&A

• AO15 - Cell and Molecular Biology
• AO16 - Clinical Respiratory Medicine
  Herbert Wang Chun Kwok Chairperson Hong Kong
• AO17 - COPD
  Boon Hau Ng Chairperson Malaysia
• AO18 - Interstitial Lung Disease
  Gin Tsen Chai Chairperson Singapore
• AO19 - Lung Cancer
• AO20 - Pulmonary Circulation
• AO21 - Tuberculosis
  Diego Silva Chairperson Australia

• From Virus to Bacteria: An Integrated Strategy for Preventing Severe Adult Respiratory Disease
  Wei Chih Chen Speaker Taiwan

• Changing Course in COPD: Breaking the Exacerbation Cycle
  David Price Speaker Singapore